Table 6.
KEGG pathways.
| Description | Count in gene set | False discovery rate |
|---|---|---|
| Pathways in cancer | 28 | 1.08 × 10–15 |
| PI3K-Akt signaling pathway | 24 | 1.11 × 10–15 |
| EGFR tyrosine kinase inhibitor resistance | 12 | 3.19 × 10–11 |
| Metabolic pathways | 33 | 1.13 × 10–10 |
| Ras signaling pathway | 16 | 1.46 × 10–10 |
| Proteoglycans in cancer | 15 | 1.78 × 10–10 |
| MAPK signaling pathway | 17 | 3.66 × 10–10 |
| Endocrine resistance | 11 | 1.93 × 10–09 |
| AGE-RAGE signaling pathway in diabetic complications | 11 | 2.33 × 10–09 |
| Rap1 signaling pathway | 14 | 2.33 × 10–09 |